{"brief_title": "A Study to Compare the Safety and Effectiveness of Two Dosing Schedules of Lamivudine in Combination With Two Other Anti-HIV Drugs", "brief_summary": "The purpose of this study is to compare the safety and effectiveness of 2 dosing schedules (once daily vs twice daily) of lamivudine (3TC) given with stavudine (d4T) and either indinavir (IDV) or nelfinavir (NFV) for 24 weeks.", "detailed_description": "Patients are randomized to 1 of 2 groups. Group 1 receives 3TC qd plus d4T plus either IDV or NFV. Group 2 receives 3TC bid plus d4T plus either IDV or NFV. Patients are evaluated for drug tolerance, medication adherence, and genotypic and phenotypic resistance.", "condition": ["HIV Infections"], "intervention_type": ["Drug", "Drug", "Drug", "Drug"], "intervention_name": ["Indinavir sulfate", "Nelfinavir mesylate", "Lamivudine", "Stavudine"], "criteria": "Inclusion Criteria Patients may be eligible for this study if they: - Are HIV-positive. - Are at least 18 years old. - Have had an HIV level below 400 copies/ml for at least 3 months prior to study entry. - Have a CD4 cell count of at least 50 cells/mm3. - Are currently taking an anti-HIV drug regimen that includes 3TC plus d4T plus either IDV or NFV for at least 6 months prior to study entry. (Note: This must be their first anti-HIV drug regimen.) - Agree to abstain from sex or use effective methods of birth control during the study. Exclusion Criteria Patients will not be eligible for this study if they: - Have a history of an AIDS-defining illness or certain other medical conditions. - Are allergic to any of the study drugs. - Are unable to take medication by mouth for any reason. - Have received certain medications. - Will need to receive radiation therapy or chemotherapy (for any cancer other than Kaposi's sarcoma) during the study. - Are pregnant or breast-feeding.", "gender": "All", "minimum_age": "18 Years", "maximum_age": "N/A", "healthy_volunteers": "No", "keyword": "Anti-HIV Agents", "mesh_term": ["Infection", "HIV Infections", "Nelfinavir", "Indinavir", "Stavudine", "Lamivudine"], "id": "NCT00002442"}